Skip to content

PSX Pharmaceuticals

IBLHL IBL HealthCare Limited

Latest results: FY2026 · Jun 2026

FY2026 revenue Rs 4.6 bn (+6.6%), profit Rs 220.4 mn (+5.8%).

Last close · 13 Nov 2026

Rs 40.83 ▼ 0.02 (-0.05%)

▼ 25.9% 1 year

15 Oct 22 Oct 28 Oct 3 Nov 11 Nov Jun Jul Aug Sep Oct Dec Feb May Jul Oct 2022 2023 2024 2025 2026
36.0052-week range85.82
Market cap
—
P/E
18.2×
FY2026
Sector 12.6× · higher
P/B
—
FY2026
Dividend yield
—
FY2026
ROE
9.1%
FY2026
Sector 21.7% · lower
EPS
Rs 2.24
FY2026
Book value / share
—
FY2026

Fundamentals

IBLHL at a glance

Revenue · FY2026

Rs 4.6 bn

▲ 6.6% year on year

Profit attributable to shareholders · FY2026

Rs 220.4 mn

▲ 5.8% year on year

EPS – basic (Rs) · FY2026

Rs 2.24

▲ 6.0% year on year

Net margin · FY2026

4.8%

0.0 pts year on year

Debt to equity · FY2026

1.0%

-5.8 pts year on year

Price performance

IBLHL returns

Close Rs 40.83
13 Nov 2026

Period Return Rs
MTD +4.9% −2.0 pts vs KSE +1.90
3M −17.0% −15.8 pts vs KSE −8.37
6M −11.3% −17.5 pts vs KSE −5.19
YTD −36.2% −38.4 pts vs KSE −23.12
FYTD −23.0% −21.6 pts vs KSE −12.19
1Y −25.9% −36.6 pts vs KSE −14.29
Long term
3Y +33.1% +10.0% a year −181.6 pts vs KSE +10.16
5Y −21.5% −4.7% a year −310.3 pts vs KSE −11.21

Price return from the last close before each period; the fiscal year ends 30 June. Dividends are not included.

IBL HealthCare Limited in brief

IBL HealthCare Limited (IBLHL) reported revenue of Rs 4.6 bn for FY2026 (Jul 2025 – Jun 2026), up 6.6% from FY2025.

Profit attributable to shareholders was Rs 220.4 mn (EPS Rs 2.24), up 5.8%, a net margin of 4.8%.

The balance sheet showed net cash of Rs 700.6 mn.

Return on equity was 9.1%.

Over the last five years revenue grew at a compound 8.9% a year.

At Rs 40.83 (close on 13 Nov 2026) the shares trade at 18.2× earnings (FY2026).

Scorecard vs Pharmaceuticals

14 companies
Growth
Weak
4.6%
Profitability
Weak
4.8%
Financial health
Strong
1.0%
Valuation
Below average
18.2×
Dividends
No figure
—

Ratings place the company in its sector: growth (3-year revenue growth), profitability (net margin; return on equity for banks, insurers and finance companies), financial health (debt to equity, industrial companies), valuation (P/E at today's price) and dividends (yield at today's price). Five dots = top fifth. Rated within the sector when at least four companies report the figure, otherwise against all PSX companies of the same type (marked vs PSX). Information, not investment advice.

Corporate

IBLHL announcements & payouts

All IBLHL announcements →
29 Oct 2026 · 11:00
Result · First quarter to 30 Sep 2026
Profit after tax
Rs 64.1 mn
EPS
Rs 0.65 -19.8%
EPS a year earlier
Rs 0.81
23 Sep 2026 · 15:46
Result · Full year to 30 Jun 2026 AGM 27 Oct
Profit after tax
Rs 220.4 mn
EPS
Rs 2.24 -7.8%
EPS a year earlier
Rs 2.43

Book closure 19 Oct – 27 Oct 2026

30 Apr 2026 · 10:51
Result · Nine months to 31 Mar 2026
Profit after tax
Rs 167.5 mn
EPS
Rs 1.70 +7.6%
EPS a year earlier
Rs 1.58
25 Feb 2026 · 11:50
Result · Half year to 31 Dec 2025
Profit after tax
Rs 105.6 mn
EPS
Rs 1.07 -8.5%
EPS a year earlier
Rs 1.17

Financial highlights

IBLHL financial results

IBLHL annual financial highlights (Rs mn)
Rs mn FY2026 Jul 2025 – Jun 2026 FY2025 Jul 2024 – Jun 2025 FY2024 Jul 2023 – Jun 2024 FY2023 * Jul 2022 – Jun 2023 FY2022 Jul 2021 – Jun 2022 FY2021 Jul 2020 – Jun 2021 FY2020 Jul 2019 – Jun 2020 FY2019 Jul 2018 – Jun 2019 FY2018 Jul 2017 – Jun 2018 FY2017 Jul 2016 – Jun 2017
Revenue 4,607.1 4,322.5 3,603.4 4,027.9 3,651.1 3,003.9 2,664.6 1,585.0 1,358.3 1,189.8
Gross profit 1,644.8 1,447.0 951.8 1,340.4 1,256.2 1,022.5 811.3 443.9 428.5 397.9
Operating profit — 444.6 143.3 631.7 582.6 438.8 352.6 204.1 213.7 254.0
Profit after tax 220.4 208.4 7.6 309.0 302.9 300.5 220.0 121.4 149.3 198.4
Profit attributable to shareholders 220.4 208.4 7.6 309.0 302.9 300.5 220.0 121.4 149.3 198.4
EPS – basic (Rs) Rs 2.24 2.11 0.08 3.14 2.56 3.05 2.23 1.23 1.52 2.01
Dividend per share (Rs) Rs — 0.00 0.00 0.00 0.72 0.55 1.10 0.55 0.55 0.50
Total assets 4,034.2 4,010.0 3,326.8 3,553.7 2,929.5 2,446.7 2,252.0 1,888.8 1,399.9 1,317.1
Total equity 2,543.5 2,323.1 2,114.7 2,107.1 1,863.1 1,614.3 1,422.0 1,256.0 1,188.8 1,088.6
Total debt 26.6 159.0 22.4 297.6 267.2 258.7 178.7 167.5 0.0 —
Net cash from operating activities 659.2 (259.7) 568.0 27.2 56.9 70.0 40.4 12.4 63.2 144.5
Capital expenditure (5.9) (19.1) (1.6) (3.1) (1.3) (5.8) (4.7) (13.1) (6.2) (49.5)
Free cash flow (operating cash flow − capex) 653.3 (278.8) 566.4 24.0 55.6 64.2 35.8 (0.6) 57.0 95.0
IBLHL quarterly financial highlights (Rs mn)
Rs mn TTM to Jun 2026 Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024
Revenue 4,607.1 1,302.3 1,212.7 971.1 1,120.9 1,177.8 948.0 1,117.7 1,079.0
Gross profit 1,644.8 400.1 442.8 401.8 400.1 458.9 313.3 334.9 339.9
Operating profit — — 144.5 87.0 132.3 136.0 80.2 102.2 118.9
Profit after tax 220.4 52.9 61.9 35.9 69.7 72.9 35.4 40.2 59.9
Profit attributable to shareholders 220.4 52.9 61.9 35.9 69.7 72.9 35.4 40.2 59.9
EPS – basic (Rs) Rs — — 0.63 0.36 0.70 0.74 0.36 0.41 0.61
Dividend per share (Rs) Rs — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 4,034.2 4,034.2 4,343.1 4,340.4 4,188.9 4,010.0 3,657.4 3,493.3 3,655.5
Total equity 2,543.5 2,543.5 2,490.5 2,428.6 2,392.7 2,323.1 2,250.1 2,214.7 2,174.5
Total debt 26.6 26.6 456.5 452.5 456.8 159.0 391.1 390.7 420.0
Net cash from operating activities 659.2 1,049.0 19.7 69.7 (479.3) 414.9 (5.9) 10.7 (679.4)
Capital expenditure (5.9) (1.1) (0.9) (1.2) (2.7) (0.8) (17.5) (0.1) (0.7)
Free cash flow (operating cash flow − capex) 653.3 1,047.9 18.8 68.6 (482.0) 414.1 (23.4) 10.6 (680.1)

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets. Free cash flow and book value per share are calculated by Smart Money; TTM = the latest four quarters. Updated 17 Oct 2026.

IBLHL charts

Revenue and profit Revenue Profit attributable
Revenue and profit Rs 5 bn Revenue FY17: Rs 1.2 bn Profit attributable FY17: Rs 198.4 mn FY17 Revenue FY18: Rs 1.4 bn Profit attributable FY18: Rs 149.3 mn FY18 Revenue FY19: Rs 1.6 bn Profit attributable FY19: Rs 121.4 mn FY19 Revenue FY20: Rs 2.7 bn Profit attributable FY20: Rs 220.0 mn FY20 Revenue FY21: Rs 3.0 bn Profit attributable FY21: Rs 300.5 mn FY21 Revenue FY22: Rs 3.7 bn Profit attributable FY22: Rs 302.9 mn FY22 Revenue FY23: Rs 4.0 bn Profit attributable FY23: Rs 309.0 mn FY23 Revenue FY24: Rs 3.6 bn Profit attributable FY24: Rs 7.6 mn FY24 Revenue FY25: Rs 4.3 bn Profit attributable FY25: Rs 208.4 mn FY25 Revenue FY26: Rs 4.6 bn Profit attributable FY26: Rs 220.4 mn FY26
Margins Gross margin Operating margin Net margin
Margins 39% 19% 0% Gross margin FY17: 33.4% Gross margin FY18: 31.5% Gross margin FY19: 28.0% Gross margin FY20: 30.4% Gross margin FY21: 34.0% Gross margin FY22: 34.4% Gross margin FY23: 33.3% Gross margin FY24: 26.4% Gross margin FY25: 33.5% Gross margin FY26: 35.7% Operating margin FY17: 21.3% Operating margin FY18: 15.7% Operating margin FY19: 12.9% Operating margin FY20: 13.2% Operating margin FY21: 14.6% Operating margin FY22: 16.0% Operating margin FY23: 15.7% Operating margin FY24: 4.0% Operating margin FY25: 10.3% Net margin FY17: 16.7% Net margin FY18: 11.0% Net margin FY19: 7.7% Net margin FY20: 8.3% Net margin FY21: 10.0% Net margin FY22: 8.3% Net margin FY23: 7.7% Net margin FY24: 0.2% Net margin FY25: 4.8% Net margin FY26: 4.8% FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26
Cash flow Operating cash flow Capex Free cash flow
Cash flow Rs 659 mn -Rs 279 mn Operating cash flow FY17: Rs 144.5 mn Capex FY17: -Rs 49.5 mn Free cash flow FY17: Rs 95.0 mn FY17 Operating cash flow FY18: Rs 63.2 mn Capex FY18: -Rs 6.2 mn Free cash flow FY18: Rs 57.0 mn FY18 Operating cash flow FY19: Rs 12.4 mn Capex FY19: -Rs 13.1 mn Free cash flow FY19: -Rs 623,000 FY19 Operating cash flow FY20: Rs 40.4 mn Capex FY20: -Rs 4.7 mn Free cash flow FY20: Rs 35.8 mn FY20 Operating cash flow FY21: Rs 70.0 mn Capex FY21: -Rs 5.8 mn Free cash flow FY21: Rs 64.2 mn FY21 Operating cash flow FY22: Rs 56.9 mn Capex FY22: -Rs 1.3 mn Free cash flow FY22: Rs 55.6 mn FY22 Operating cash flow FY23: Rs 27.2 mn Capex FY23: -Rs 3.1 mn Free cash flow FY23: Rs 24.0 mn FY23 Operating cash flow FY24: Rs 568.0 mn Capex FY24: -Rs 1.6 mn Free cash flow FY24: Rs 566.4 mn FY24 Operating cash flow FY25: -Rs 259.7 mn Capex FY25: -Rs 19.1 mn Free cash flow FY25: -Rs 278.8 mn FY25 Operating cash flow FY26: Rs 659.2 mn Capex FY26: -Rs 5.9 mn Free cash flow FY26: Rs 653.3 mn FY26

Valuation

IBLHL valuation at today's price

Price to earnings (P/E)
18.2×
EPS Rs 2.24 (FY2026)
Price to book (P/B)
—
Book value — (FY2026)
Dividend yield
—
DPS — (FY2026)
Earnings yield
5.5%
EPS ÷ price

At the closing price of Rs 40.83 on 13 Nov 2026. P/E and P/B are not shown when earnings or book value are negative.

Sector peers

IBLHL vs Pharmaceuticals companies

Largest companies in the sector at today's prices
Company Market cap P/E P/B Yield ROE 3-yr growth
IBLHL — 18.2× — — 9.1% 4.6%
GLAXO Rs 107.1 bn 10.3× 3.11× 5.1% 32.4% 16.3%
ABOT Rs 97.9 bn 11.4× 3.05× 4.0% 28.8% 15.2%
HALEON Rs 81.6 bn 12.4× 5.02× 4.3% 47.6% 16.2%
HINOON Rs 50.8 bn 12.8× 3.95× 5.2% 32.3% 20.5%
AGP Rs 43.8 bn 11.7× 2.92× 5.1% 25.9% 26.0%
HPL Rs 38.5 bn 10.3× 4.50× 6.0% 38.6% 18.6%
FEROZ Rs 15.8 bn 16.1× 1.19× 1.5% 7.6% 27.9%
CPHL Rs 14.5 bn 18.3× 1.34× 0.0% 7.3% 4.3%

All Pharmaceuticals companies, medians and leaders →

Analyses & signals 0

Win rate — · 0 closed signals · average return —

No analyses published for IBLHL yet.

IBLHL: frequently asked questions

What is IBLHL's EPS?

IBL HealthCare Limited reported basic earnings per share of Rs 2.24 for FY2026 (Jul 2025 – Jun 2026).

What is IBLHL's P/E ratio?

At the closing price of Rs 40.83 on 13 Nov 2026, IBLHL trades at a P/E of 18.2× based on EPS of Rs 2.24 (FY2026).

What was IBLHL's revenue and profit in FY2026?

IBL HealthCare Limited reported revenue of Rs 4.6 bn and profit attributable to shareholders of Rs 220.4 mn for FY2026 (Jul 2025 – Jun 2026).

How has IBLHL's share price performed?

IBLHL's share price is down 36.2% year to date (KSE-100: +2.2%), down 25.9% over one year (KSE-100: +10.7%) and down 21.5% over five years (KSE-100: +288.8%), as of 13 Nov 2026. These are price returns; dividends are not included.

Information only, not investment advice.